Xiangxue Pharmaceutical Co (SZSE:300147) Risk Assessment

View and export this data going back to 2010. Start your Free Trial

What is Xiangxue Pharmaceutical Co Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of Xiangxue Pharmaceutical Co is: High Risk: High uncertainty with risk-return tradeoff.

Competitive Comparison of Xiangxue Pharmaceutical Co's Risk Assessment

For the Biotechnology subindustry, Xiangxue Pharmaceutical Co's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Xiangxue Pharmaceutical Co's Risk Assessment Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Xiangxue Pharmaceutical Co's Risk Assessment distribution charts can be found below:

* The bar in red indicates where Xiangxue Pharmaceutical Co's Risk Assessment falls into.

Xiangxue Pharmaceutical Co (SZSE:300147) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

Xiangxue Pharmaceutical Co Risk Assessment Related Terms

Thank you for viewing the detailed overview of Xiangxue Pharmaceutical Co's Risk Assessment provided by GuruFocus.com. Please click on the following links to see related term pages.

Xiangxue Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Xiangxue Pharmaceutical Co Ltd (SZSE:300147) » Definitions » Risk Assessment

Comparable Companies

Traded in Other Exchanges

N/A

Address

No 2 Jinfeng Road , Science City, Guangzhou Economic and Technological Development Z, Guangzhou, CHN, 510663

Website

http://www.xphcn.com

Xiangxue Pharmaceutical Co Ltd is a China-based company engages in the manufacture and distribution of pharmaceutical products. Its diversified healthcare portfolio includes Chinese Herbal Slices, TCM, Life Science, Biomedical Engineering health solutions (food and beverage), healthcare supplements and so on.

Executives

Huang Wei Hua	Supervisors
Tan Wen Hui	Director
Kang Zhi Ying	Executives
Ceng Lun	Executives
Liu Yan	Executives
Lu Feng	Executives
Xu Li	Secretary, Director
Mo Zi Yu	Supervisors
Mai Zhen Jiang	Supervisors
Wang Yong Hui	Directors, executives
He Tao	Executives
Fang Wei Min	Supervisors
Huang Bin	Directors, Directors, and Executives
Wu Jun	Executives
Chen Wen Jin	Executives

Xiangxue Pharmaceutical Co Headlines

No Headlines